Company news
Amgen Inc. news in 2020
Amgen Inc.'s news releases, calls and decks from 2020, newest first.
Amgen Submits Sotorasib Marketing Authorization Application To The European Medicines Agency
December 21, 2020
Amgen Awards Two Local Biotech Start-Ups With Golden Ticket To LabCentral
December 16, 2020
Amgen Announces 10% Increase In 2021 First Quarter Dividend
December 15, 2020
Amgen's Sotorasib Granted Breakthrough Therapy Designation For Advanced Or Metastatic Non-Small Cell Lung Cancer Patients With KRAS G12C Mutation
December 7, 2020
Amgen Announces New Data Being Presented At ASH 2020
November 29, 2020
Amgen To Transition Development And Commercial Rights For Omecamtiv Mecarbil And AMG 594 To Cytokinetics
November 22, 2020
Amgen Presents First Clinical Data for AMG 757 at SITC 2020
November 8, 2020
Amgen Reports Third Quarter 2020 Financial Results
October 27, 2020
Amgen Announces Webcast Of 2020 Third Quarter Financial Results
October 26, 2020
Amgen Announces 2020 Fourth Quarter Dividend
October 20, 2020
Amgen, Cytokinetics and Servier Announce Topline Results From GALACTIC-HF, a Phase 3 Trial of Omecamtiv Mecarbil in Patients With Heart Failure
October 7, 2020
Amgen Announces Positive Topline Phase 2 Results For Investigational KRAS G12C Inhibitor Sotorasib In Advanced Non-Small Cell Lung Cancer
October 4, 2020
Amgen Announces Five-Year Data That Reinforce The Safety And Efficacy Profile Of Aimovig® (erenumab-aooe) In Adult Patients With Episodic Migraine
October 2, 2020
Amgen To Showcase Data From Oncology Pipeline During ESMO Virtual Congress 2020
September 15, 2020
Amgen Announces Positive Data From Phase 3B Study Of Repatha® (Evolocumab) In Pediatric Patients With Heterozygous Familial Hypercholesterolemia At ESC Congress 2020
August 28, 2020
FDA Approves New KYPROLIS® (carfilzomib) Combination Regimen With DARZALEX® (daratumumab) And Dexamethasone In Both Once- And Twice-Weekly Dosing Regimens
August 19, 2020
Amgen Announces Pricing Terms For Senior Notes Exchange Offers, Increases The Maximum Notes Exchange Cap And Accepts Tendered Notes
August 12, 2020
Amgen Commences Exchange Offers For Certain Series Of Outstanding Senior Notes From Exchange Eligible Holders
July 29, 2020
Amgen Reports Second Quarter 2020 Financial Results
July 27, 2020
Amgen Announces Webcast Of 2020 Second Quarter Financial Results
July 22, 2020
Amgen Foundation Awards Khan Academy An Additional $3 Million To Support Science Learning And Educational Equity Amid COVID-19
July 20, 2020
Amgen Announces Additional Investment In BeiGene
July 11, 2020
Amgen Announces Global Diagnostic Collaborations To Expand Molecular Testing For Patients With Non-Small Cell Lung Cancer
January 12, 2020
Calls in 2020
Decks in 2020
- Investor Presentation (May 2020)
Investor deck · 18 slides · May 27, 2020